Bacteriostatic Water: Why 0.9% Benzyl Alcohol Is the USP Standard for Peptide Reconstitution
USP-grade bacteriostatic water with 0.9% benzyl alcohol: pH, 28-day multidose use, neonatal gasping warning (CDC MMWR 1982) and peptide stability.
Bacteriostatic water is the quiet workhorse of peptide research. It is not glamorous, and most researchers order it almost automatically alongside their peptide vials. But the question of which diluent you choose decides how long a reconstituted peptide stays usable, whether microbial contamination remains controlled across multiple punctures, and whether the formulation follows pharmacopoeial standards at all.
USP-grade sterile water with 0.9% benzyl alcohol - the standard solvent for reconstituting lyophilized peptides. Essential accessory for any peptide research. Each vial is sealed and ready to use.
What Is Bacteriostatic Water?
Bacteriostatic water for injection (BWFI) is sterile water containing an added antimicrobial agent, almost always benzyl alcohol at 0.9% (9 mg/mL) or, in some formulations, 1.1% (11 mg/mL). Per United States Pharmacopeia (USP) monograph and the Pfizer reference labeling, the solution has a pH around 5.7 (acceptable range 4.5 to 7.0) and is intended for use as a diluent for drugs administered parenterally after reconstitution.
The decisive word is bacteriostatic, not bactericidal. Benzyl alcohol does not kill existing bacteria on contact. It suppresses their growth, which is the property that makes the vial safe to re-enter with a new needle during a typical 28-day in-use period.
Why 0.9% Benzyl Alcohol?
The 0.9% concentration is not arbitrary. It is the level that reliably inhibits growth of common contaminants introduced during needle entry, while remaining below the concentrations that cause significant local irritation in typical small-volume reconstitutions. The USP allows a 28-day multidose window once the vial is broached, and the benzyl alcohol carries the preservation load across that window.
Researchers who substitute sterile water without preservative lose this protection. A broached vial of plain sterile water is a single-use product. Repeated punctures invite contamination that a bacteriostatic agent would otherwise suppress.
USP Standard at a Glance
Pfizer/USP bacteriostatic water for injection: 0.9% (9 mg/mL) benzyl alcohol, pH target 5.7 (range 4.5-7.0), sterile, non-pyrogenic, multidose vial, maximum 28-day in-use period after first puncture. Source: Pfizer label LAB-0446, USP monograph for Bacteriostatic Water for Injection.
Benzyl Alcohol Safety and the Neonatal Warning
The single most important safety note on any bacteriostatic water label is the neonatal contraindication. In 1982, the CDC published an MMWR report describing a cluster of neonatal deaths linked to flush solutions containing benzyl alcohol. The clinical picture - metabolic acidosis, respiratory failure, hypotension and a distinctive agonal breathing pattern - was called Gasping Syndrome.
The mechanism was later tied to benzyl alcohol metabolism into benzoic acid, which premature neonates cannot efficiently conjugate and clear. The parallel NEJM publication by Gershanik and colleagues (NEJM 1982; 307:1384-8) documented ten affected infants and became the pharmacovigilance anchor for every subsequent benzyl alcohol label warning.
The European Medicines Agency expresses the limit quantitatively. Benzyl alcohol exposures above roughly 100 to 200 mg/kg/24 h in children under three have been associated with toxicity. Bacteriostatic water is therefore explicitly excluded from neonatal and low-weight paediatric use in both FDA and EMA labeling.
Critical Contraindication
Bacteriostatic water with benzyl alcohol is not suitable for neonates, premature infants, or low-weight paediatric subjects in any research or clinical setting. The 1982 Gasping Syndrome cases remain the defining safety reference. For research work that touches this population, sterile water for injection without preservative is the only acceptable diluent.
BAC Water vs. Sterile Water vs. Bactericidal Water
The three labels look similar and are regularly confused. They are not interchangeable.
| Property | Bacteriostatic Water | Sterile Water for Injection | Bactericidal Water |
|---|---|---|---|
| Preservative | 0.9% benzyl alcohol | None | Varies (e.g. phenol) |
| Multidose use | Yes, 28 days | No, single use only | Product-specific |
| pH | 4.5-7.0 | 5.0-7.0 | Varies |
| Neonatal use | Contraindicated | Preferred | Usually contraindicated |
| Typical role | Peptide reconstitution, multidose vials | Single-entry dilutions, neonatal work | Niche antimicrobial roles |
For lyophilised peptides reconstituted across several draws over weeks, bacteriostatic water is the default diluent. For single-use preparations or neonatal research contexts, sterile water for injection is chosen instead.
Peptide Stability After Reconstitution
The diluent is only half of the stability equation. Once reconstituted, peptide solutions are sensitive to temperature, light and repeated temperature cycling. GenScript and Bachem both publish handling guidelines that converge on the same practical rules.
Most reconstituted research peptides are kept refrigerated at 2 to 8 °C and used within two to four weeks, with the outer limit tracking the 28-day multidose window of the bacteriostatic water itself. Light-sensitive peptides (BPC-157, GHK-Cu, several cathelicidin fragments) should be stored in amber vials or wrapped in foil. Freeze-thaw cycles degrade most peptides measurably, so small working aliquots are preferable to repeated freezing of a full vial.
Storage After Reconstitution
After reconstitution in bacteriostatic water: store at 2 to 8 °C, protect from light, avoid freeze-thaw cycles, and respect the 28-day in-use window. Do not exceed four weeks even if the solution still looks clear - benzyl alcohol preservation is defined for that window, not beyond.
Quality Criteria
Not every bottle labelled "bacteriostatic water" meets pharmacopoeial standards. Three markers separate a research-grade product from a dubious one.
First, the label must specify the benzyl alcohol concentration (0.9% or 1.1%) and reference USP or equivalent EP/BP monograph compliance. A label that only says "bacteriostatic water" without the active concentration is incomplete.
Second, the vial must be a genuine sterile closure, typically a rubber-stoppered glass vial of 10, 20 or 30 mL with an aluminium cap. Ampoule-only formats without a preservative claim are usually sterile water, not bacteriostatic water.
Third, a production lot should have a batch number, expiry date, and ideally a manufacturer-issued certificate of sterility. Without these, the 28-day in-use assumption cannot be defended.
Practical Use: Reconstitution Basics
Bacteriostatic water is almost always used to dissolve a lyophilised peptide. The procedure matters more than most researchers assume - rough handling denatures the peptide before it ever enters the solution.
EU Shipping
For researchers in the European Union, sourcing a USP-grade bacteriostatic water from within the EU avoids customs delays and temperature excursions typical of long-haul shipments. PeptidesDirect ships from within the EU with tracked delivery in two to three working days, and every lot is released against documented sterility and benzyl alcohol concentration specifications.
Summary
Bacteriostatic water is not a generic accessory. It is a pharmacopoeial formulation with defined concentration (0.9% benzyl alcohol), defined pH (around 5.7), a defined in-use window (28 days) and a defined contraindication (neonates, after Gasping Syndrome). Researchers who treat it as interchangeable with plain sterile water lose both multidose stability and the quality-control chain that makes peptide reconstitution reproducible.
USP-grade sterile water with 0.9% benzyl alcohol - the standard solvent for reconstituting lyophilized peptides. Essential accessory for any peptide research. Each vial is sealed and ready to use.